OwlTail

Cover image of Merck Sharp

Merck Sharp Podcasts

Read more

3 of The Best Podcast Episodes for Merck Sharp. A collection of podcasts episodes with or about Merck Sharp, often where they are interviewed.

Read more

3 of The Best Podcast Episodes for Merck Sharp. A collection of podcasts episodes with or about Merck Sharp, often where they are interviewed.

Updated daily with the latest episodes

Episode artwork

(CAFC 2019-11-07) Merck Sharp & Dohme Corp. v. Wyeth LLC

Play
Read more

U.S. Court of Appeals for the Federal Circuit

Appeal number:2018-2133

Issue: Whether the PTAB's decision declining to find a claim unpatentable as obvious should be upheld.

Merck Sharp & Dohme Corp. v. Wyeth LLC

Disclaimer: PatentCases is a non-for-profit podcast channel that republishes freely available recordings related to U.S. patent cases. PatentCases does not have any right in the audio files being re-shared.

Dec 04 2019 · 39mins
Episode artwork

SCOTUS Merck Sharp & Dohme Corp. v. Albrecht, Case No. 17-290

Play
Read more
Federalism: Is a state-law failure-to-warn claim preempted when the FDA rejected the drug manufacturer’s proposal to warn about the same risk? - Argued: Mon, 07 Jan 2019 13:39:42 EDT
Jan 11 2019 ·

Similar People

Hernandez v. Mesa

v. Lewis

Allen v. Cooper

Biestek v. Berryhill

Benisek v. Lamone

Gill v. Whitford

Collins v. Virginia

McCoy v. Louisiana

Kisor v. Wilkie

Abbott v. Perez

Bucklew v. Precythe

Mathena v. Malvo

Encino Motorcars

Barton v. Barr

Jeffrey S. Sutton

Episode artwork

Courthouse Steps Oral Argument: Merck Sharp & Dohme Corp. v. Albrecht

Play
Read more
In Merck Sharp & Dohme Corp. v. Albrecht, the Supreme Court has been asked to clarify the nature of the evidence defendants must produce to demonstrate that state law tort claims are preempted by federal law and whether such questions may be submitted to a jury. The Third Circuit rejected defendants’ contention that preemption was a purely legal issue for the court to decide and suggested that defendants must demonstrate that there is a “high probability” that the FDA would have rejected stronger labeling for a pharmaceutical product in order to invoke preemption. Doug Smith will attend the oral argument and then join us to discuss his thoughts on the proceedings.
Featuring:
Douglas G. Smith, P.C., Partner, Kirkland & Ellis LLP

Teleforum calls are open to all dues paying members of the Federalist Society. To become a member, sign up on our website. As a member, you should receive email announcements of upcoming Teleforum calls which contain the conference call phone number. If you are not receiving those email announcements, please contact us at 202-822-8138.
Jan 11 2019 · 28mins